External Innovation & Strategic M&A for Life Science Companies
Your challenge
You are pursuing external innovation through acquisitions, strategic investments, or partnerships. The challenge lies in identifying the right targets, ensuring strategic fit, and executing transactions that create long-term value rather than short-term distraction.
Our solution
We partner with you across the full M&A lifecycle – from defining your external innovation strategy to identifying, evaluating, and executing transactions. Our structured, science- and data-driven approach ensures strategic alignment, disciplined execution, and sustainable growth.
What you get
-
M&A and external innovation strategy tailored to your growth agenda
-
Systematic target identification and strategic fit assessment
-
End-to-end transaction support from strategy to closing
Your project, step-by-step
Define your acquisition strategy
-
We align your strategic objectives for external innovation
-
We define acquisition criteria and strategic fit parameters
-
We prioritize technology, product, or platform areas
Identify and assess targets
-
We sharpen your strategic narrative and investor positioning
-
We prepare transaction materials and key messages
-
We define the optimal transaction structure and timeline
Execute the transaction
-
We support your due diligence and valuation process
-
We assist in transaction structuring and execution
-
We support decision-making until signing and closing
Deliverables
-
M&A and external innovation strategy
-
Longlist and shortlist of target companies
-
End-to-end transaction execution support